权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Roles of Eukaryotic Translation Initiation Factors in Gene Expression

真核翻译起始因子在基因表达中的作用

基本信息

批准号：
9175075
负责人：
GERHARD WAGNER
金额：
$ 38.77万
依托单位：
HARVARD MEDICAL SCHOOL
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-07-20 至 2021-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9175075
关键词：
3&apos Untranslated Regions 5&apos Untranslated Regions Antineoplastic Agents Apoptosis Binding Binding Proteins Biochemical Biological Assay C-terminal Cancer cell line Cell Culture Techniques Complex Development Disease EIF4EBP1 gene Elements Equilibrium Eukaryotic Initiation Factors Event Exhibits Gene Expression Genetic Translation Goals Homeostasis Housing Human In Vitro Initiator Codon Libraries Ligands Malignant Neoplasms Maps Measures Mediating Messenger RNA Methods Migration Assay Molecular Molecular Machines Mus Neoplasm Metastasis Oncogenes Oncogenic Outcome Peptide Initiation Factors Phosphoproteins Phosphorylation Phosphotransferases Process Protein Biosynthesis Proteins Proteomics RNA RNA Binding RNA Cap-Binding Proteins RNA Helicase Recruitment Activity Regulation Research Resolution Ribosomes Role Route Scaffolding Protein Scanning Signal Pathway Specificity Structure Testing Translation Initiation Translations Tumor Promoters Tumor Suppressor Proteins Untranslated Regions Xenograft procedure base cancer therapy cell transformation design fighting genetic regulatory protein high throughput screening human disease in vivo inhibitor/antagonist interest mutant new therapeutic target novel novel anticancer drug particle prevent research study small molecule small molecule therapeutics

项目摘要

Summary The goal of this project is to elucidate basic mechanisms of eukaryotic translation initiation using structural and other biochemical methods. Eukaryotic translation initiation is highly regulated by elements of the untranslated regions of mRNAs, 5'UTR and 3'UTR, by the cellular concentration of initiation factors, by the action of regulatory proteins and by signaling pathways that are initiated by external messages or cellular events. Dysregulation of translation initiation by elevated levels of initiation factors is found in many forms of cancer. Thus, correcting for out-of-balance initiation with small molecule agents is a promising new route for cancer therapy. The proposed research is focused on the mechanisms by which the small ribosomal particle is recruited to mRNA, mediated by the initiation factors eIF4E, eIF4G and the regulatory phosphoprotein 4EBP-1. The second aspect is focused on scanning of the pre-initiation complex to the AUG initiation codon, aided by the interplay between the initiation factors eIF4A, eIF4G and eIF4H. The third topic is on elucidating the interaction of the Mnk1/2 kinases with the HEAT3 domain of eIF4G and its role in phosphorylating eIF4E, which has been related to metastasis. A significant aspect is to discover and characterize inhibitors of initiation with the goal of developing anti-cancer agents with broad specificity. The research will pursue three specific aims: 1. Regulation of the eIF4E/eIF4G interaction by 4EBP proteins and inhibitors 2. Analyze and target the eIF4G interactions with eIF4A, RNA and eIF4H. 3. Inhibit eIF4G-MNK1/2 interaction to prevent eIF4E phosphorylation and cancer metastases.

总结